Lymph node removal vs no removal after ESD for early esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial compares two approaches for early-stage esophageal cancer: removing nearby lymph nodes versus not removing them, after a standard endoscopic removal of the tumor. The goal is to see if removing lymph nodes improves outcomes for patients with T1a stage cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage esophageal cancer (T1aN0M0) confirmed by endoscopic ultrasound.
- You are between 18 and 75 years old.
- You sign a consent form to participate.
- You have not had surgery on your chest or esophagus before.
- You have not had radiation or chemotherapy before.
- You do not have any other current or past cancers (except this one).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of finding and removing lymph nodes during esophageal cancer surgery. One uses a special dye (indocyanine green) to highlight lymph nodes, and the other is the standard method. The goal is to see if the dye method is as effective as the standard method while possibly being less invasive.
This study compares two ways to treat a type of esophagus cancer: surgical removal (esophagectomy) versus chemoradiation (chemo plus radiation). It is for people with early-stage findings where scans suggest no lymph node spread.
This trial is testing a combination of chemotherapy and radiation (called total neoadjuvant therapy) before surgery for a type of esophageal cancer that has spread to lymph nodes. The goal is to see if this approach improves outcomes.
This trial looks at how often a specific lymph node (106TBL) is involved in esophageal squamous cell carcinoma. It may help guide treatment decisions for people who have not had other cancers and whose tumor is in the chest (not the neck).
This trial tests whether removing nearby lymph nodes is enough, or if additional stomach-sparing surgery is needed, after a previous endoscopic procedure did not completely remove early stomach cancer. The goal is to see which approach is better for preventing cancer from spreading.
This trial tests a new way to remove lymph nodes during surgery for esophageal cancer after you've already had chemo and immunotherapy. The goal is to see if guiding lymph node removal with a special technique helps improve outcomes.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.